These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1344608)

  • 21. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Infections in polymyositis and in dermatomyositis].
    Marie I
    Presse Med; 2009 Feb; 38(2):303-16. PubMed ID: 19084369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic options in dermatomyositis/polymyositis.
    Boyd AS; Neldner KH
    Int J Dermatol; 1994 Apr; 33(4):240-50. PubMed ID: 8021077
    [No Abstract]   [Full Text] [Related]  

  • 24. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myositis associated with tumors].
    András C; Ponyi A; Constantin T; Csiki Z; Illés A; Szegedi G; Dankó K
    Magy Onkol; 2002; 46(3):253-9. PubMed ID: 12368921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal acute interstitial pneumonitis complicating polymyositis in a 41-year-old man.
    Aoun NY; Velez E; Aggarwal A; Hayes GB; Kenney LA
    Respir Care; 2004 Dec; 49(12):1515-21. PubMed ID: 15571643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment-resistant inflammatory myopathy.
    Mann HF; Vencovsky J; Lundberg IE
    Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):427-40. PubMed ID: 20534375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application.
    Danieli MG; Pettinari L; Moretti R; Logullo F; Gabrielli A
    Autoimmun Rev; 2011 Jan; 10(3):144-9. PubMed ID: 20858553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
    Chérin P; Herson S
    Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-fluorodeoxyglucose-Avid mammary mass in a patient with insulin-dependent diabetes mellitus and Hodgkin's lymphoma: relapse or pitfall?
    Gurion R; Groshar D; Schindel A; Shpilberg O; Raanani P
    Isr Med Assoc J; 2006 Dec; 8(12):838-9. PubMed ID: 17214098
    [No Abstract]   [Full Text] [Related]  

  • 31. Tuberculous pyomyositis.
    Mootsikapun P; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    J Med Assoc Thai; 2003 May; 86(5):477-81. PubMed ID: 12859107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppression in Type I diabetes mellitus].
    Schönle EJ; Sizonenko PC; Spinas GA
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1225-7. PubMed ID: 2237051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Will type I diabetes mellitus be treated with immunosuppressive drugs in the future?].
    Diem P
    Ther Umsch; 1993 Feb; 50(2):114-8. PubMed ID: 8456415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis].
    Ito S; Miyamae T; Imagawa T; Katakura S; Mori M; Tomono J; Ibe M; Mituda T; Aihara Y; Yokota S
    Ryumachi; 1998 Dec; 38(6):785-92. PubMed ID: 10047716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of polymyositis].
    Ueda K; Ito M; Matsumoto K; Kuroda K; Ishibe T
    Naika; 1970 Apr; 25(4):634-45. PubMed ID: 5423419
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of tacrolimus in a case of polymyositis].
    Joki H; Yamaguchi S; Segawa F; Kuroiwa Y
    Rinsho Shinkeigaku; 2005 Feb; 45(2):121-4. PubMed ID: 15782611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome in polymyositis and dermatomyositis.
    Bronner IM; van der Meulen MF; de Visser M; Kalmijn S; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; Hoogendijk JE
    Ann Rheum Dis; 2006 Nov; 65(11):1456-61. PubMed ID: 16606652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Established and new treatments of the idiopathic inflammatory myopathies: dermatomyositis and polymyositis.
    Pipitone N; Salvarani C
    Clin Exp Rheumatol; 2007; 25(6):896-906. PubMed ID: 18173928
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2004 Jun; 25 Suppl 1():S22-5. PubMed ID: 15165688
    [No Abstract]   [Full Text] [Related]  

  • 40. [Secondary amyloidosis in Hodgkin's disease].
    Khristov V; Belovezhdov N; Zlateva S
    Vutr Boles; 1977; 16(4):102-4. PubMed ID: 919507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.